VeriMompeg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
Related ingredients
Frequently asked questions
- peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) est-il sûr pendant l'allaitement ?
- No data identified showing reproductive or lactation toxicity or transfer in breast milk for this ingredient. Mechanistic or animal evidence of transfer into milk was not found; expected systemic exposure from topical cosmetic use is low but measurable, so marginal potential for maternal systemic exposure exists. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) est-il sûr pour la peau de bébé ?
- No infant‑specific toxicity or developmental data were identified. Because the ingredient is a PEGylated benzotriazole UV‑absorber (moderate molecular size) and topical absorption in infants is typically higher than in adults, exposure score is increased by +1 for baby skin; however no evidence was found indicating intrinsic reproductive/developmental hazard. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed, EWG.
- Comment VeriMom évalue-t-il peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) ?
- VeriMom évalue peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.